Form D · Other Investment Fund
Janus Henderson Biotech Innovation Fund II Ltd
Grand Cayman, E9 · CIK 0002034032
Offering snapshot reported Aug 18, 2025 · SEC filing
- Reported sold
- $402M Indefinite offering
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 18, 2025 | Amendment | $402,000,000 | No comparison | Not reported | SEC filing |
| Aug 15, 2024 | Initial | $150,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-521667
Source: Form D, filed Aug 18, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matteo Candolfini | Director |
| Toby Hiscock | Director |
| N/A Janus Henderson Investors Us Llc | Promoter |
| Kenneth M.B. Lubbock | Director |
| Hugh Ward | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
Maples Corporate Services Limited Box 309, Ugland House
Grand Cayman, E9, KY1-1104
Grand Cayman, E9, KY1-1104